Incidental Adrenal Histoplasmosis Revealed by FAPI PET-CT in an Immunocompetent Patient.

IF 0.5 Q4 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING
Indian Journal of Nuclear Medicine Pub Date : 2025-01-01 Epub Date: 2025-05-16 DOI:10.4103/ijnm.ijnm_143_24
Sairam Doppalapudi, Ashish Mohite, Rumaanah Khan, Karuna Luthra
{"title":"Incidental Adrenal Histoplasmosis Revealed by FAPI PET-CT in an Immunocompetent Patient.","authors":"Sairam Doppalapudi, Ashish Mohite, Rumaanah Khan, Karuna Luthra","doi":"10.4103/ijnm.ijnm_143_24","DOIUrl":null,"url":null,"abstract":"<p><p>A 77-year-old male presented with pyrexia of unknown origin. Chest computed tomography (CT) showed adrenal lesions, a suspicion of neoplasia was raised, and Fluorodeoxyglucose Positron Emission Tomography (FDG PET-CT) was recommended. Since the patient had uncontrolled diabetes (Fasting Blood Sugar - 326 mg/dL), FDG-PET was not feasible. The patient, therefore, underwent Ga68-Fibroblast Activating Protein Inhibitor - 46 PET-CT (FAPI PET-CT). Scan showed high-grade Fibroblast Activating Protein (FAP) expression in bilateral enlarged adrenals. Findings appeared atypical for malignancy and the possibility of chronic inflammatory/infectious condition was raised. Biopsy proved adrenal histoplasmosis (AH). Although FDG avidity in AH is known and previously reported, this is best to our knowledge the first literature documentation of FAP expression in AH.</p>","PeriodicalId":45830,"journal":{"name":"Indian Journal of Nuclear Medicine","volume":"40 1","pages":"49-50"},"PeriodicalIF":0.5000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12121846/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Indian Journal of Nuclear Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4103/ijnm.ijnm_143_24","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/5/16 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING","Score":null,"Total":0}
引用次数: 0

Abstract

A 77-year-old male presented with pyrexia of unknown origin. Chest computed tomography (CT) showed adrenal lesions, a suspicion of neoplasia was raised, and Fluorodeoxyglucose Positron Emission Tomography (FDG PET-CT) was recommended. Since the patient had uncontrolled diabetes (Fasting Blood Sugar - 326 mg/dL), FDG-PET was not feasible. The patient, therefore, underwent Ga68-Fibroblast Activating Protein Inhibitor - 46 PET-CT (FAPI PET-CT). Scan showed high-grade Fibroblast Activating Protein (FAP) expression in bilateral enlarged adrenals. Findings appeared atypical for malignancy and the possibility of chronic inflammatory/infectious condition was raised. Biopsy proved adrenal histoplasmosis (AH). Although FDG avidity in AH is known and previously reported, this is best to our knowledge the first literature documentation of FAP expression in AH.

免疫功能正常患者的FAPI PET-CT显示偶发性肾上腺组织胞浆菌病。
一名77岁男性出现不明原因的发热。胸部计算机断层扫描(CT)显示肾上腺病变,怀疑有肿瘤,建议采用氟脱氧葡萄糖正电子发射断层扫描(FDG PET-CT)。由于患者患有未控制的糖尿病(空腹血糖- 326 mg/dL), FDG-PET不可行。因此,患者接受了ga68 -成纤维细胞激活蛋白抑制剂- 46 PET-CT (FAPI PET-CT)检查。扫描显示双侧肾上腺肥大的成纤维细胞激活蛋白(FAP)高水平表达。恶性肿瘤表现不典型,可能为慢性炎症/感染性疾病。活检证实肾上腺组织浆菌病(AH)。虽然在AH中FDG的表达是已知的,并且之前也有报道,但据我们所知,这是关于FAP在AH中表达的第一次文献记录。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Indian Journal of Nuclear Medicine
Indian Journal of Nuclear Medicine RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING-
CiteScore
0.70
自引率
0.00%
发文量
46
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信